13F HOLDINGS REPORT
Ghost Tree Capital, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001420506-24-001501
Total Value
$319.3M
Positions
63
Other Managers
0
Confidential Omitted
No
Holdings (63)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOHAVEN LTD | BHVN | 490,000 | $17.0M | 5.33% |
| 2 | ALNYLAM PHARMACEUTICALS INC | ALNY | 68,400 | $16.6M | 5.20% |
| 3 | INSMED INC | INSM | 200,000 | $13.4M | 4.20% |
| 4 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 300,000 | $13.2M | 4.13% |
| 5 | SOLENO THERAPEUTICS INC | SLNO | 300,000 | $12.2M | 3.83% |
| 6 | AXSOME THERAPEUTICS INC | AXSM | 150,000 | $12.1M | 3.78% |
| 7 | ASCENDIS PHARMA A/S | ASND | 86,721 | $11.8M | 3.70% |
| 8 | VAXCYTE INC | PCVX | 150,000 | $11.3M | 3.55% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 240,000 | $10.7M | 3.37% |
| 10 | ROIVANT SCIENCES LTD | ROIV | 1,000,000 | $10.6M | 3.31% |
| 11 | PERSPECTIVE THERAPEUTICS INC | CATX | 925,000 | $9.2M | 2.89% |
| 12 | TG THERAPEUTICS INC | TGTX | 500,000 | $8.9M | 2.79% |
| 13 | SAREPTA THERAPEUTICS INC | SRPT | 55,000 | $8.7M | 2.72% |
| 14 | CG ONCOLOGY INC | CGON | 260,000 | $8.2M | 2.57% |
| 15 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 175,000 | $7.9M | 2.48% |
| 16 | VIRIDIAN THERAPEUTICS INC | VRDN | 587,708 | $7.6M | 2.39% |
| 17 | SYNDAX PHARMACEUTICALS INC | SNDX | 350,000 | $7.2M | 2.25% |
| 18 | IMMUNOVANT INC | IMVT | 260,000 | $6.9M | 2.15% |
| 19 | TARSUS PHARMACEUTICALS INC | TARS | 235,000 | $6.4M | 2.00% |
| 20 | PHATHOM PHARMACEUTICALS INC | PHAT | 600,000 | $6.2M | 1.94% |
| 21 | REZOLUTE INC | RZLT | 1,421,501 | $6.1M | 1.91% |
| 22 | OLEMA PHARMACEUTICALS INC | OLMA | 550,000 | $6.0M | 1.86% |
| 23 | SPYRE THERAPEUTICS INC | SYRE | 250,237 | $5.9M | 1.84% |
| 24 | ALNYLAM PHARMACEUTICALS INC | ALNY | 22,500 | $5.5M | 1.71% |
| 25 | APELLIS PHARMACEUTICALS INC | APLS | 135,000 | $5.2M | 1.62% |
| 26 | VIKING THERAPEUTICS INC | VKTX | 95,000 | $5.0M | 1.58% |
| 27 | RHYTHM PHARMACEUTICALS INC | RYTM | 117,388 | $4.8M | 1.51% |
| 28 | INSMED INC | INSM | 65,000 | $4.4M | 1.36% |
| 29 | BLUEPRINT MEDICINES CORP | 09627Y109 | 40,000 | $4.3M | 1.35% |
| 30 | SAVARA INC | SVRA | 1,050,876 | $4.2M | 1.33% |
| 31 | TENAYA THERAPEUTICS INC | TNYA | 1,350,000 | $4.2M | 1.31% |
| 32 | REPLIMUNE GROUP INC | REPL | 450,000 | $4.0M | 1.27% |
| 33 | ENGENE HOLDINGS INC | ENGNW | 420,331 | $4.0M | 1.24% |
| 34 | ACADIA PHARMACEUTICALS INC | ACAD | 225,000 | $3.7M | 1.14% |
| 35 | BRIDGEBIO PHARMA INC | BBIO | 140,000 | $3.5M | 1.11% |
| 36 | KORRO BIO INC | KRRO | 100,000 | $3.4M | 1.06% |
| 37 | NUVATION BIO INC | NUVB | 1,150,000 | $3.4M | 1.05% |
| 38 | HELIX ACQUISITION CORP II | HLXC | 300,000 | $3.1M | 0.96% |
| 39 | TAYSHA GENE THERAPIES INC | TSHA | 1,250,000 | $2.8M | 0.88% |
| 40 | CABALETTA BIO INC | CABA | 370,899 | $2.8M | 0.87% |
| 41 | NEUROGENE INC | NGNE | 70,000 | $2.5M | 0.80% |
| 42 | JANUX THERAPEUTICS INC | JANX | 50,000 | $2.1M | 0.66% |
| 43 | ARVINAS INC | ARVN | 75,000 | $2.0M | 0.63% |
| 44 | REGENXBIO INC | RGNX | 170,000 | $2.0M | 0.62% |
| 45 | CYTOKINETICS INC | CYTK | 33,200 | $1.8M | 0.56% |
| 46 | ELEVATION ONCOLOGY INC | 28623U101 | 600,000 | $1.6M | 0.51% |
| 47 | KRYSTAL BIOTECH INC | KRYS | 8,500 | $1.6M | 0.49% |
| 48 | ANNEXON INC | ANNX | 310,000 | $1.5M | 0.48% |
| 49 | PROQR THRAPEUTICS N V | N71542109 | 900,000 | $1.5M | 0.47% |
| 50 | ATYR PHARMA INC | ATYR | 800,000 | $1.2M | 0.39% |
| 51 | ANNEXON INC | ANNX | 214,500 | $1.1M | 0.33% |
| 52 | WAVE LIFE SCIENCES LTD | WVE | 200,000 | $998,000 | 0.31% |
| 53 | RAPT THERAPEUTICS INC | 75382E109 | 300,000 | $915,000 | 0.29% |
| 54 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 35,000 | $909,650 | 0.28% |
| 55 | SAGIMET BIOSCIENCES INC | SGMT | 225,000 | $769,500 | 0.24% |
| 56 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 10,000 | $684,900 | 0.21% |
| 57 | MACROGENICS INC | MGNX | 150,000 | $637,500 | 0.20% |
| 58 | PMV PHARMACEUTICALS INC | PMVP | 375,000 | $607,500 | 0.19% |
| 59 | PTC THERAPEUTICS INC | PTCT | 19,000 | $581,020 | 0.18% |
| 60 | REVANCE THERAPEUTICS INC | 761330109 | 225,000 | $578,250 | 0.18% |
| 61 | INTELLIA THERAPEUTICS INC | NTLA | 25,000 | $559,500 | 0.18% |
| 62 | AN2 THERAPEUTICS INC | ANTX | 219,331 | $471,562 | 0.15% |
| 63 | CYTOMX THERAPEUTICS INC | CTMX | 300,000 | $366,000 | 0.11% |